Definitive Contract 75N93019C00073
Award Date
9/16/19
Potential Completion Date
9/15/24
Potential Value
$7.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Integral Molecular Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,500,000.00 Firm Fixed Price Definitive Contract to Integral Molecular Inc., a small business biotechnology company, for the development of antibody reagents to support immunologic analysis of underrepresented mammalian models. This contract is part of the Small Business Innovation Research (SBIR) Program Phase II. Integral Molecular specializes in membrane protein research and has received prior contracts and grants...
This contract award is to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and antibody development. The contract, valued at $150,000.00, was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I research project focused on biomedical research. It is designated as a total small business set-aside. Integral Molecular...
This is a $600,000 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and therapeutic antibody development. The contract is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models", supporting...
This is a $7,910,444.00 definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Integral Molecular Inc. The contract is for discovering and characterizing B cell epitopes against the viral pathogens Rift Valley Fever Virus, Crimean-Congo Hemorrhagic Fever Virus, and Enterovirus D68. The contract has a period of performance from September 16, 2024 to September 15, 2029 and was not set...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $600,000 firm-fixed-price definitive contract to Integral Molecular Inc., a small business biotechnology company, for "ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES." The contract has a completion date of June 29, 2024. Integral Molecular specializes in membrane protein research and has received numerous federal contracts and grants from agencies like the National Institutes of...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $16,200 purchase order to Integral Molecular Inc. for membrane proteome array services (AMBIS #2194825). The firm fixed price contract will be performed in Philadelphia, Pennsylvania from November 21, 2023 through January 31, 2024. As part of NIH's efforts to advance biomedical research, this award will provide Integral Molecular services to analyze protein...
This federal contract award was issued by the Office of Intergovernmental and External Affairs, a civilian agency, to Integral Molecular Inc., a biotechnology company based in Philadelphia, Pennsylvania. The award, valued at $85,800.00, is for the provision of medical research supplies to the Centers for Disease Control and Prevention (CDC) in Thailand to support COVID-19 research. The contract is a firm fixed-price purchase order with a completion date of July 30, 2021. The award was not set...
The U.S. Department of Defense's Defense Health Agency awarded a $61,233.40 firm fixed-price purchase order to Integral Molecular Inc., a biotechnology company, for the provision of laboratory supplies to support the U.S. Embassy in Bangkok, Thailand. The contract has a period of performance through November 12, 2024 and did not utilize a set-aside. Integral Molecular Inc. is a for-profit organization that specializes in innovative technologies and therapeutic antibodies for membrane protein...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Battelle Memorial Institute, a large nonprofit research and development organization. The contract, valued at $6,398,512.00, is for clinical sample testing of SARS-CoV-2 vaccine candidates. This is a cost-plus-fixed-fee type contract that will run through April 17, 2025. The contract has several subcontractors, including Integral...
This is a $36,549,202.01 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for the Immune Epitope and Analysis Program. The contract has no set-aside designation and is set to run until December 14, 2025. As the prime contractor, the La Jolla Institute for Immunology is responsible for the overall program, which involves conducting research and providing services related to...